We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Online learning module on reducing the side effects of steroid medicines to help clinicians to optimise the use of corticosteroids.
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the identified risk of disabling and potentially long-lasting or...
Advice for medical professionals to follow when assessing drivers with miscellaneous conditions.
The results of a scoping study on the fate and behaviour of oestrone seventeen oestradiol and ethinyl oestradiol in rivers.
Men who inject anabolic steroids and tanning drugs are at higher risk of HIV and viral hepatitis.
Details of the council's committees and latest meeting minutes.
Rarely, severe adverse effects can occur on stopping treatment with topical corticosteroids, often after long-term continuous or inappropriate use of moderate to high potency products. To reduce the risks of these events, prescribe the topical corticosteroid of lowest potency needed...
The Medicines and Healthcare products Regulatory Agency has today issued a recall asking patients to return affected products.
Risk of early psychiatric side-effects is one of several important safety issues for healthcare professionals to discuss with patients and carers, who should seek urgent medical advice in the event of any worrying symptoms.
PSO 3601 sets out the requirements and procedures for the conduct of mandatory drug testing (MDT) in prisons.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).